PharmOncology

Ming-Hei Tai

A podcast about pharmacy and oncology

Strona podcastu

Słuchaj w swojej aplikacji

Odcinki

29 odcinków

  1. A Review of DeLLphi-305 12:49
  2. Is daraxonrasib actually pan-RAS? 11:57
  3. How hepatotoxic is tucatinib? 11:16
  4. How do ADCs actually work? 9:48
  5. Why MMAE beat MMAF 11:01
  6. Explaining CELMoDs in 10 minutes 9:22
  7. Why current HER2 testing is flawed 11:48
  8. VIKTORIA-1: Appropriate control arm? 11:40
  9. The Fc region of antibodies 9:22
  10. CIRCULATE and ctDNA positivity rates 8:33
  11. Interpreting prospective ctDNA trials 14:43